skip to main content

    Updated Visitor Guidelines

 

MENU

 

Keller to oversee shared resources at Rogel Cancer Center

The University of Michigan Rogel Cancer Center has named Evan T. Keller, D.V.M., Ph.D., associate director for shared resources.

What Breast Cancer and Ovarian Cancer Survivors Should Know About New Genetic Testing Recommendations

Breast cancer and/or ovarian cancer survivors should be offered genetic counseling and genetic testing for BRCA1 and BRCA2 genetic mutations, according to new recommendations from the U.S. Preventive Services Task Force.

Donation Form Confirmation

Thank you for your interest in leaving your legacy with Michigan Medicine!

You will be contacted within 24 business hours (excluding weekends and holidays) by the Brain Tumor Program Coordinator.

Improving Equity in Academic Medicine

Christina Chapman, M.D. studies ways to improve equity in health care systems and the medical workforce to better meet the needs of the population.

Michigan Drug Discovery Invests in New Cancer Drugs

Since 2012, Michigan Drug Discovery has invested more than $2.3 million in more than 70 projects. Now, they are funding three projects led by Rogel Cancer Center researchers. Each project is looking to find new treatments for cancer.

Pages